Does Withdrawing Steroids Increase Flares?

Save

Dr. Janet Pope reports on abstract OP0180 presented at Eular 2024 in Vienna, Austria.

We've Got To Talk About CAR T Cells

Save

Dr. Yuz Yusof discusses abstract OP0017 presented at the Eular 2024 meeting in Vienna, Austria.

EULAR 2024 Daily Podcasts Day1&2

Save

Do we need more IL-17 and JAK Inhibitors in Spondyloarthritis? Dr. Eric Ruderman shares his perspectives on the following abstracts being presented at Eular 2024 in Vienna, Austria: OP0195 Sonelokimab IL 17 A/F nanobody inhibitor LB0005 Izokibep IL17A nanobody inhibitor POS0803 Vunakizumab, another IL17A inhibitor OP0138 TAK-279 phase 2B selective TYK2 inhibitor Zasocitinib Transition from Psoriasis to PsA: Can we Prevent It? Dr.

Predicting Palindromic Prognosis

Save

Dr. David Liew discusses abstract OP0127 at Eular 2024 in Vienna, Austria.

A Step Closer to Identifying Phenotypes of RA ILD

Save

Dr. Mrinalini Dey discusses abstract OP0202 presented at Eular 2024 in Vienna, Austria.

Top 3 Messages About JAK Inhibitor Safety

Save

Dr. Janet Pope discusses a debate she participated in at Eular 2024 in Vienna, Austria, and her top three messages regarding JAKi safety.

Pain in RA: Different Drugs for Different Mechanisms

Save

Dr. Aurelie Najm reports from Eular 2024 in Vienna, Austria, about abstracts OP0072 and OP0086.

Giant Cell Arteritis and Polymyalgia Rheumatica Update

Save

Dr. Janet Pope discusses abstracts LBA0001, OP0233, OP0261 and POS0280 at Eular 2024 in Vienna, Austria.

JAK Inhibitors For New Indications

Save

Dr. Janet Pope discusses new indications for JAK inhibitors, reporting from Eular 2024 in Vienna, Austria.

Top 3 Messages About JAK Inhibitor Safety

Save

Dr. Janet Pope discusses a debate she participated in at Eular 2024 in Vienna, Austria, and her top three messages regarding JAKi safety.

Pain in RA: Different Drugs for Different Mechanisms

Save

Dr. Aurelie Najm reports from Eular 2024 in Vienna, Austria, about abstracts OP0072 and OP0086.

JAK Inhibitors For New Indications

Save

Dr. Janet Pope discusses new indications for JAK inhibitors, reporting from Eular 2024 in Vienna, Austria.

Potential Of Radiomics To Predict TNF Ther

Save

Dr. Bella Mehta interviews Dr. Vincenzo Venerito about abstract POS0236 at Eular 2024 in Vienna, Austria.

Treat To Target Outcomes In Early AxSpA

Save

Dr. Antoni Chan discusses abstract OP0132 presented at Eular 2024 in Vienna, Austria.

Does Telemonitoring In SpA Work?

Save

https://mcdn.podbean.com/mf/web/u7su8m4f495pxtr8/Potential_of_Radiomics…